UNITAID
  • Home
  • Who we are
    • The NGO delegation
    • Unitaid
  • How we work
    • Governance
    • Upcoming board meetings
  • Publications
    • Press releases and advocacy
    • Board meeting reports
    • News from UNITAID
  • Get involved
Select Page

The Medicines Patent Pool and Abbvie Sign Licensing Agreement to Increase Access to Crucial HIV treatments Throughout Africa

by Alysa | Dec 18, 2015 | UNITAID News

Geneva, 18 December 2015 — The Medicines Patent Pool (MPP) today announced a new licensing agreement with AbbVie, a global biopharmaceutical company, that seeks to address future demands for HIV treatment Lopinavir/Ritonavir (LPV/r) in South Africa and across Africa....

Recent Posts

  • Welcome to our new Key Advisors!
  • Why and How Unitaid should continue to invest in HIV, TB, and Malaria
  • Opportunities and challenges associated with new technologies for prevention, diagnosis, and treatment 
  • We are recruiting – Key Advisor
  • We are recruiting – Alternate Board Member (June 2021)

Recent Comments

    Archives

    • May 2022
    • February 2022
    • January 2022
    • June 2021
    • March 2021
    • July 2020
    • June 2020
    • December 2018
    • August 2018
    • March 2016
    • January 2016
    • December 2015
    • November 2015
    • March 2015
    • February 2015

    Categories

    • Press Release
    • Uncategorized
    • UNITAID News

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    • Facebook
    • Twitter
    • Google
    • RSS

    Designed by Elegant Themes | Powered by WordPress